NORTH TIDE CAPITAL, LLC
Follow13F filer, CIK 1557543, BOSTON, MA
NORTH TIDE CAPITAL, LLC reported $584,942,000 across 15 holdings for the quarter ended 2016-12-31, in a 13F-HR filed 2017-02-14. Its ten largest share positions make up 88.65% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001140361-17-006734
- Period
- 2016-12-31
- Reported value
- $585M
- Holdings
- 15
- Top 10 weight
- 88.65%
- New
- 3
- Sold out
- 5
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| IMPAX LABORATORIES INCnew | +2,000,000 | $26.5M |
| ALLERGAN PLCnew | +100,000 | $21M |
| ARAYnew | +1,000,000 | $4.6M |
| MYGNadded | +150,000 | $2.5M |
| KINDRED HEALTHCARE INCadded | +250,000 | $1.96M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| CYHexited | -5,500,000 | -$63.5M |
| VALEANT PHARMACEUTICALS INTLexited | -2,000,000 | -$49.1M |
| MYLAN NVreduced | -1,250,000 | -$47.7M |
| PRGOexited | -500,000 | -$46.2M |
| SEMreduced | -3,100,000 | -$41.1M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q4 2016
Share positions as resolved from 13F-HR 0001140361-17-006734, largest first. % of portfolio is the value over $584,944,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| SEMSELECT MED HLDGS CORP | 10,000,000 | $132M | 22.65% | -3,100,000 | Timeline | ||
| HEALTHWAYS INCHEALTHWAYS INC | 4,500,000 | $102M | 17.5% | 0 | |||
| SUPERVALU INCSUPERVALU INC | 18,469,921 | $86.3M | 14.75% | -6,030,079 | |||
| GILDGILEAD SCIENCES INC | 500,000 | $35.8M | 6.12% | -300,000 | Timeline | ||
| KINDRED HEALTHCARE INCKINDRED HEALTHCARE INC | 4,250,000 | $33.4M | 5.7% | +250,000 | |||
| SYNERON MEDICAL LTDSYNERON MEDICAL LTD | 3,500,000 | $29.4M | 5.03% | 0 | |||
| MYLAN NVMYLAN NV | 750,000 | $28.6M | 4.89% | -1,250,000 | |||
| IMPAX LABORATORIES INCIMPAX LABORATORIES INC | 2,000,000 | $26.5M | 4.53% | new | |||
| LIFEPOINT HEALTH INCLIFEPOINT HEALTH INC | 400,000 | $22.7M | 3.88% | -100,000 | |||
| ALLERGAN PLCALLERGAN PLC | 100,000 | $21M | 3.59% | new | |||
| MYGNMYRIAD GENETICS INC | 1,150,000 | $19.2M | 3.28% | +150,000 | Timeline | ||
| QUORUM HEALTH CORPQUORUM HEALTH CORP | 2,500,000 | $18.2M | 3.11% | 0 | |||
| VIVUS INCVIVUS INC | 13,587,460 | $15.6M | 2.67% | 0 | |||
| BIOSCRIP INCBIOSCRIP INC | 8,500,000 | $8.84M | 1.51% | 0 | |||
| ARAYACCURAY INC DEL | 1,000,000 | $4.6M | 0.79% | new | Timeline |
Sold out in Q4 2016
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| CYHCOMMUNITY HEALTH SYS INC NEW | 5,500,000 | $63.5M | shares |
| VALEANT PHARMACEUTICALS INTLVALEANT PHARMACEUTICALS INTL | 2,000,000 | $49.1M | shares |
| PRGOPERRIGO CO PLC | 500,000 | $46.2M | shares |
| ALMOST FAMILY INCALMOST FAMILY INC | 700,000 | $25.7M | shares |
| ADUSADDUS HOMECARE CORP | 174,079 | $4.55M | shares |
How Q4 2016 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001140361-17-006734 | base | 2017-02-14 | acceptance time not in the bulk data set |